hat
Silodosin (komès non Rapaflo (nan Etazini), Silodyx (an Ewòp ak Afwik disid), Rapilif (Zend), Silodal (Zend), Urief (Japon), Thrupas (Kore di sid), Urorec (Lawisi)) se yon renmèd pou tretman reprezantatif de hyperplasie la san danje. Li bagay tankou yon rival α1-adrenoceptor ak uroselectivity anwo nan syèl la (sélectivité pou pwostat a). Cho baj:Mirabegron.
eng
Silodosin (trade names Rapaflo (USA), Silodyx (Europe and South Africa), Rapilif (India), Silodal (India), Urief (Japan), Thrupas (South Korea), Urorec (Russia)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).Hot tags: Mirabegron .